22 August 2020 : Clinical Research
Dynamin 2 Is Correlated with Recurrence and Poor Prognosis of Papillary Thyroid Cancer
Ning Ren1BCF, Zhenmin Tian2CE, Hongmei Sun3BD, Xiaofei Lu4ABCDEF*DOI: 10.12659/MSM.924590
Med Sci Monit 2020; 26:e924590
Table 2 Correlation between disease-free survival (DFS) and clinicopathological factors.
| Variables | DFS time | P* |
|---|---|---|
| Sex | ||
| Male | 63.3 | 0.711 |
| Female | 55.3 | |
| Age (years) | ||
| <45 | 60.3 | 0.177 |
| ≥45 | 54.0 | |
| Tumor size (cm) | ||
| ≤2 | 57.0 | 0.608 |
| >2 | 52.3 | |
| Tumor number | ||
| Single | 65.1 | 0.576 |
| Multiple | 56.9 | |
| Differentiation | ||
| Good | 68.2 | 0.043 |
| Moderate | 50.5 | |
| Site | ||
| Left/right | 72.1 | 0.814 |
| Left+right | 54.9 | |
| T stage | ||
| I+II | 60.4 | 0.700 |
| III+IV | 46.9 | |
| N stage | ||
| N0 | 58.8 | 0.773 |
| N1 | 58.9 | |
| TNM stage | ||
| I+II | 58.3 | 0.924 |
| III+IV | 60.8 | |
| Dynamin 2 | ||
| Low | 30.8 | 0.030 |
| High | 67.6 | |
| * Calculated by the log-rank test. TNM – tumor-node-metastasis. | ||